Name: Latest research reports of Torrent Pharmaceuticals Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Torrent Pharmaceuticals Ltd.
Rating: 3
Author: Motilal Oswal

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer

3599.3000 -7.40 (-0.21%)

NSE Sep 04, 2025 15:31 PM

Near 52W High of ₹3787.90

Volume: 128.4K

Torrent Pharmaceuticals Ltd.

23 Jul 2024

3599.30

-0.21%

India/Germany businesses drive earnings

Neutral: Torrent Pharmaceuticals Ltd.

Target

Motilal Oswal

Torrent Pharma (TRP) delivered largely in-line 1QFY25. TRP posted robust 14.7% YoY growth in domestic formulation (DF) segment.

Torrent Pharmaceuticals Ltd. is trading above its 200 day SMA of 3298.2